Leptin and Soluble Leptin Receptor in Risk of Colorectal Cancer in the European Prospective Investigation into Cancer and Nutrition Cohort

Autor: Petra H.M. Peeters, Marc J. Gunter, Rudolf Kaaks, Kim Overvad, Fränzel J.B. Van Duijnhoven, Francesca L. Crowe, Aurelio Barricarte, Anne Tjønneland, Antoine Racine, Stefan Söderberg, Richard Palmqvist, Françoise Clavel-Chapelon, Isabelle Romieu, Krasimira Aleksandrova, Heiner Boeing, Jytte Halkjær, Virginia Menéndez, Tobias Pischon, José María Huerta, María José Sánchez, Annekatrin Lukanova, H. Bas Bueno-de-Mesquita, Dimitrios Trichopoulos, Naomi E. Allen, Mazda Jenab, Nickolas Wareham, Valeria Pala, Veronika Fedirko, Sabina Rinaldi, Marie-Christine Boutron-Ruault, Antonia Trichopoulou, Domenico Palli, Amalia Mattiello, Eugene Jansen, Elio Riboli, Pilar Amiano, Kay-Tee Khaw, Genevieve Buckland, Pagona Lagiou, Rosario Tumino, Sabine Westphal, Paolo Vineis
Jazyk: angličtina
Rok vydání: 2012
Předmět:
Zdroj: Aleksandrova, K, Boeing, H, Jenab, M, Bueno-de-Mesquita, H B, Jansen, E, van Duijnhoven, F J B, Rinaldi, S, Fedirko, V, Romieu, I, Riboli, E, Gunter, M J, Westphal, S, Overvad, K, Tjønneland, A, Halkjær, J, Racine, A, Boutron-Ruault, M-C, Clavel-Chapelon, F, Kaaks, R, Lukanova, A, Trichopoulou, A, Lagiou, P, Trichopoulos, D, Mattiello, A, Pala, V, Palli, D, Tumino, R, Vineis, P, Buckland, G, Sánchez, M-J, Amiano, P, Huerta, J M, Barricarte, A, Menéndez, V, Peeters, P H, Söderberg, S, Palmqvist, R, Allen, N E, Crowe, F L, Khaw, K-T, Wareham, N & Pischon, T 2012, ' Leptin and Soluble Leptin Receptor in Risk of Colorectal Cancer in the European Prospective Investigation into Cancer and Nutrition Cohort ', Cancer Research, vol. 72, no. 20, pp. 5328-5337 . https://doi.org/10.1158/0008-5472.CAN-12-0465
Popis: Leptin, a peptide hormone produced primarily by the adipocytes, is hypothesized to play a role in the pathogenesis of colorectal cancer (CRC). Soluble leptin receptor (sOB-R) may regulate leptin's physiologic functions; however its relation to CRC risk is unknown. This study explored the association of leptin and sOB-R with risk of CRC in a prospective nested case-control study within the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. A total of 1,129 incident CRC cases (713 colon, 416 rectal) were matched within risk sets to 1,129 controls. Conditional logistic regression was used to calculate relative risks (RR) and 95% confidence intervals (CI). After multivariable adjustment including body mass index (BMI), waist circumference, and baseline leptin concentrations, sOB-R was strongly inversely associated with CRC (RR comparing the highest quintile vs. the lowest, 0.55; 95% CI, 0.40–0.76; Ptrend = 0.0004) and colon cancer (RR, 0.42; 95% CI, 0.28–0.63, Ptrend = 0.0001); whereas no association was seen for rectal cancer (RR adjusted for BMI and waist circumference, 0.83; 95% CI, 0.48–1.44, Ptrend = 0.38). In contrast, leptin was not associated with risk of CRC (RR adjusted for BMI and waist circumference, 0.85; 95% CI, 0.56–1.29, Ptrend = 0.23). Additional adjustments for circulating metabolic biomarkers did not attenuate these results. These novel findings suggest a strong inverse association between circulating sOB-R and CRC risk, independent of obesity measures, leptin concentrations, and other metabolic biomarkers. Further research is needed to confirm the potentially important role of sOB-R in CRC pathogenesis. Cancer Res; 72(20); 5328–37. ©2012 AACR.
Databáze: OpenAIRE